Evaxion Biotech A/S - ADR

General ticker "EVAX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $7.2M

Evaxion Biotech A/S - ADR does not follow the US Stock Market performance with the rate: -38.3%.

Estimated limits based on current volatility of 6.5%: low 0.85$, high 0.97$

Factors to consider:

  • Current price 71.0% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.13$, 11.56$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.74$, 6.61$]

Financial Metrics affecting the EVAX estimates:

  • Negative: Non-GAAP EPS, $ of -6.76 <= 0.10
  • Negative: Operating profit margin, % of -99.67 <= 1.03
  • Negative: Operating cash flow per share per price, % of -47.70 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term EVAX quotes

Long-term EVAX plot with estimates

Financial data

YTD 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.07MM
Operating Expenses $25.26MM $22.27MM
Operating Income $-25.26MM $-22.20MM
Non-Operating Income $1.32MM $-0.72MM
Interest Expense $1.51MM $0.90MM
R&D Expense $17.06MM $11.92MM
Income(Loss) $-23.94MM $-22.91MM
Taxes $-0.77MM $-0.79MM
Profit(Loss) $-23.17MM $-22.12MM
Stockholders Equity $-72.66MM $-4.73MM
Assets $-58.94MM $12.89MM
Operating Cash Flow $-25.77MM $-17.69MM
Capital expenditure $0.29MM $0.09MM
Investing Cash Flow $-0.27MM $-0.09MM
Financing Cash Flow $7.85MM $10.69MM
Earnings Per Share* $-9.80 $-8.11

* EPS are Split Adjusted, recent splits may be reflected with a delay.